Shopping Cart 0
Cart Subtotal
USD 0

PDL BioPharma Inc (PDLI) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

PDL BioPharma Inc (PDLI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PDL BioPharma Inc (PDL) formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to late-stage public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. PDL is headquartered in Incline Village, Nevada, the US.

PDL BioPharma Inc Key Recent Developments

Jun 11,2018: PDL BioPharma Appoints Shlomo Yanai As Board Director

May 21,2018: PDL BioPharma Appoints Dr. Jill Jene As Vice President, Business Development

May 09,2018: PDL BioPharma Announces First Quarter 2018 Financial Results

Mar 08,2018: PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results

Nov 02,2017: PDL BioPharma Announces Third Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

PDL BioPharma Inc-Key Facts 6

PDL BioPharma Inc-Key Employees 7

PDL BioPharma Inc-Key Employee Biographies 8

PDL BioPharma Inc-Major Products and Services 9

PDL BioPharma Inc-History 10

PDL BioPharma Inc-Company Statement 12

PDL BioPharma Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

PDL BioPharma Inc-Business Description 15

Business Segment: Income Generating Assets 15

Overview 15

Performance 15

Business Segment: Medical Devices 15

Overview 15

Performance 15

Business Segment: Pharmaceutical 15

Overview 15

Performance 15

Geographical Segment: Europe 15

Performance 15

Geographical Segment: Rest of the World 16

Performance 16

Geographical Segment: United States 16

Performance 16

PDL BioPharma Inc-Corporate Strategy 17

PDL BioPharma Inc-SWOT Analysis 18

SWOT Analysis-Overview 18

PDL BioPharma Inc-Strengths 18

PDL BioPharma Inc-Weaknesses 19

PDL BioPharma Inc-Opportunities 20

PDL BioPharma Inc-Threats 21

PDL BioPharma Inc-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

PDL BioPharma Inc, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

May 09, 2018: PDL BioPharma Announces First Quarter 2018 Financial Results 33

Mar 08, 2018: PDL BioPharma Announces Fourth Quarter and Year End 2017 Financial Results 34

Nov 02, 2017: PDL BioPharma Announces Third Quarter 2017 Financial Results 36

Oct 30, 2017: Neos Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from PDL BioPharma 39

Sep 11, 2017: PDL BioPharma Appoints Dominique Monnet as President 40

Aug 03, 2017: PDL BioPharma Announces Second Quarter 2017 Financial Results 41

May 03, 2017: PDL BioPharma Announces First Quarter 2017 Financial Results 43

Mar 01, 2017: PDL BioPharma Announces Fourth Quarter and Year End 2016 Financial Results 45

Section 6-Appendix 47

Methodology 47

Ratio Definitions 47

About GlobalData 51

Contact Us 51

Disclaimer 51


List Of Figure

List of Figures

PDL BioPharma Inc, Performance Chart (2013-2017) 27

PDL BioPharma Inc, Ratio Charts 29

PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31


List Of Table

List of Tables

PDL BioPharma Inc, Key Facts 6

PDL BioPharma Inc, Key Employees 7

PDL BioPharma Inc, Key Employee Biographies 8

PDL BioPharma Inc, Major Products and Services 9

PDL BioPharma Inc, History 10

PDL BioPharma Inc, Subsidiaries 13

PDL BioPharma Inc, Key Competitors 22

PDL BioPharma Inc, Ratios based on current share price 23

PDL BioPharma Inc, Annual Ratios 24

PDL BioPharma Inc, Annual Ratios (Cont...1) 25

PDL BioPharma Inc, Annual Ratios (Cont...2) 26

PDL BioPharma Inc, Interim Ratios 28

PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

PDL BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

PDL BioPharma Inc, Recent Deals Summary 32

Currency Codes 47

Capital Market Ratios 47

Equity Ratios 48

Profitability Ratios 48

Cost Ratios 49

Liquidity Ratios 49

Leverage Ratios 50

Efficiency Ratios 50

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

PDL BioPharma Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Genmab A/S

Dyax Corp

Gilead Sciences Inc

Seattle Genetics Inc

Ocera Therapeutics Inc

Audentes Therapeutics Inc

Genentech Inc